1 Study Coverage
    1.1 Anti-Ageing Drugs Product Introduction
    1.2 Market by Type
        1.2.1 Global Anti-Ageing Drugs Market Size Growth Rate by Type, 2017 VS 2021 VS 2028
        1.2.2 Hormonal Therapy
        1.2.3 Antioxidants
        1.2.4 Enzymes
        1.2.5 Stem Cells
        1.2.6 Others
    1.3 Market by Application
        1.3.1 Global Anti-Ageing Drugs Market Size Growth Rate by Application, 2017 VS 2021 VS 2028
        1.3.2 Skin
        1.3.3 Hair
        1.3.4 Others
    1.4 Study Objectives
    1.5 Years Considered
2 Executive Summary
    2.1 Global Anti-Ageing Drugs Sales Estimates and Forecasts 2017-2028
    2.2 Global Anti-Ageing Drugs Revenue Estimates and Forecasts 2017-2028
    2.3 Global Anti-Ageing Drugs Revenue by Region: 2017 VS 2021 VS 2028
    2.4 Global Anti-Ageing Drugs Sales by Region
        2.4.1 Global Anti-Ageing Drugs Sales by Region (2017-2022)
        2.4.2 Global Sales Anti-Ageing Drugs by Region (2023-2028)
    2.5 Global Anti-Ageing Drugs Revenue by Region
        2.5.1 Global Anti-Ageing Drugs Revenue by Region (2017-2022)
        2.5.2 Global Anti-Ageing Drugs Revenue by Region (2023-2028)
    2.6 North America
    2.7 Europe
    2.8 Asia-Pacific
    2.9 Latin America
    2.10 Middle East & Africa
3 Competition by Manufacturers
    3.1 Global Anti-Ageing Drugs Sales by Manufacturers
        3.1.1 Global Top Anti-Ageing Drugs Manufacturers by Sales (2017-2022)
        3.1.2 Global Anti-Ageing Drugs Sales Market Share by Manufacturers (2017-2022)
        3.1.3 Global Top 10 and Top 5 Largest Manufacturers of Anti-Ageing Drugs in 2021
    3.2 Global Anti-Ageing Drugs Revenue by Manufacturers
        3.2.1 Global Anti-Ageing Drugs Revenue by Manufacturers (2017-2022)
        3.2.2 Global Anti-Ageing Drugs Revenue Market Share by Manufacturers (2017-2022)
        3.2.3 Global Top 10 and Top 5 Companies by Anti-Ageing Drugs Revenue in 2021
    3.3 Global Anti-Ageing Drugs Sales Price by Manufacturers (2017-2022)
    3.4 Analysis of Competitive Landscape
        3.4.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
        3.4.2 Global Anti-Ageing Drugs Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
        3.4.3 Global Anti-Ageing Drugs Manufacturers Geographical Distribution
    3.5 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type
    4.1 Global Anti-Ageing Drugs Sales by Type
        4.1.1 Global Anti-Ageing Drugs Historical Sales by Type (2017-2022)
        4.1.2 Global Anti-Ageing Drugs Forecasted Sales by Type (2023-2028)
        4.1.3 Global Anti-Ageing Drugs Sales Market Share by Type (2017-2028)
    4.2 Global Anti-Ageing Drugs Revenue by Type
        4.2.1 Global Anti-Ageing Drugs Historical Revenue by Type (2017-2022)
        4.2.2 Global Anti-Ageing Drugs Forecasted Revenue by Type (2023-2028)
        4.2.3 Global Anti-Ageing Drugs Revenue Market Share by Type (2017-2028)
    4.3 Global Anti-Ageing Drugs Price by Type
        4.3.1 Global Anti-Ageing Drugs Price by Type (2017-2022)
        4.3.2 Global Anti-Ageing Drugs Price Forecast by Type (2023-2028)
5 Market Size by Application
    5.1 Global Anti-Ageing Drugs Sales by Application
        5.1.1 Global Anti-Ageing Drugs Historical Sales by Application (2017-2022)
        5.1.2 Global Anti-Ageing Drugs Forecasted Sales by Application (2023-2028)
        5.1.3 Global Anti-Ageing Drugs Sales Market Share by Application (2017-2028)
    5.2 Global Anti-Ageing Drugs Revenue by Application
        5.2.1 Global Anti-Ageing Drugs Historical Revenue by Application (2017-2022)
        5.2.2 Global Anti-Ageing Drugs Forecasted Revenue by Application (2023-2028)
        5.2.3 Global Anti-Ageing Drugs Revenue Market Share by Application (2017-2028)
    5.3 Global Anti-Ageing Drugs Price by Application
        5.3.1 Global Anti-Ageing Drugs Price by Application (2017-2022)
        5.3.2 Global Anti-Ageing Drugs Price Forecast by Application (2023-2028)
6 North America
    6.1 North America Anti-Ageing Drugs Market Size by Type
        6.1.1 North America Anti-Ageing Drugs Sales by Type (2017-2028)
        6.1.2 North America Anti-Ageing Drugs Revenue by Type (2017-2028)
    6.2 North America Anti-Ageing Drugs Market Size by Application
        6.2.1 North America Anti-Ageing Drugs Sales by Application (2017-2028)
        6.2.2 North America Anti-Ageing Drugs Revenue by Application (2017-2028)
    6.3 North America Anti-Ageing Drugs Market Size by Country
        6.3.1 North America Anti-Ageing Drugs Sales by Country (2017-2028)
        6.3.2 North America Anti-Ageing Drugs Revenue by Country (2017-2028)
        6.3.3 U.S.
        6.3.4 Canada
7 Europe
    7.1 Europe Anti-Ageing Drugs Market Size by Type
        7.1.1 Europe Anti-Ageing Drugs Sales by Type (2017-2028)
        7.1.2 Europe Anti-Ageing Drugs Revenue by Type (2017-2028)
    7.2 Europe Anti-Ageing Drugs Market Size by Application
        7.2.1 Europe Anti-Ageing Drugs Sales by Application (2017-2028)
        7.2.2 Europe Anti-Ageing Drugs Revenue by Application (2017-2028)
    7.3 Europe Anti-Ageing Drugs Market Size by Country
        7.3.1 Europe Anti-Ageing Drugs Sales by Country (2017-2028)
        7.3.2 Europe Anti-Ageing Drugs Revenue by Country (2017-2028)
        7.3.3 Germany
        7.3.4 France
        7.3.5 U.K.
        7.3.6 Italy
        7.3.7 Russia
8 Asia Pacific
    8.1 Asia Pacific Anti-Ageing Drugs Market Size by Type
        8.1.1 Asia Pacific Anti-Ageing Drugs Sales by Type (2017-2028)
        8.1.2 Asia Pacific Anti-Ageing Drugs Revenue by Type (2017-2028)
    8.2 Asia Pacific Anti-Ageing Drugs Market Size by Application
        8.2.1 Asia Pacific Anti-Ageing Drugs Sales by Application (2017-2028)
        8.2.2 Asia Pacific Anti-Ageing Drugs Revenue by Application (2017-2028)
    8.3 Asia Pacific Anti-Ageing Drugs Market Size by Region
        8.3.1 Asia Pacific Anti-Ageing Drugs Sales by Region (2017-2028)
        8.3.2 Asia Pacific Anti-Ageing Drugs Revenue by Region (2017-2028)
        8.3.3 China
        8.3.4 Japan
        8.3.5 South Korea
        8.3.6 India
        8.3.7 Australia
        8.3.8 Taiwan
        8.3.9 Indonesia
        8.3.10 Thailand
        8.3.11 Malaysia
        8.3.12 Philippines
9 Latin America
    9.1 Latin America Anti-Ageing Drugs Market Size by Type
        9.1.1 Latin America Anti-Ageing Drugs Sales by Type (2017-2028)
        9.1.2 Latin America Anti-Ageing Drugs Revenue by Type (2017-2028)
    9.2 Latin America Anti-Ageing Drugs Market Size by Application
        9.2.1 Latin America Anti-Ageing Drugs Sales by Application (2017-2028)
        9.2.2 Latin America Anti-Ageing Drugs Revenue by Application (2017-2028)
    9.3 Latin America Anti-Ageing Drugs Market Size by Country
        9.3.1 Latin America Anti-Ageing Drugs Sales by Country (2017-2028)
        9.3.2 Latin America Anti-Ageing Drugs Revenue by Country (2017-2028)
        9.3.3 Mexico
        9.3.4 Brazil
        9.3.5 Argentina
10 Middle East and Africa
    10.1 Middle East and Africa Anti-Ageing Drugs Market Size by Type
        10.1.1 Middle East and Africa Anti-Ageing Drugs Sales by Type (2017-2028)
        10.1.2 Middle East and Africa Anti-Ageing Drugs Revenue by Type (2017-2028)
    10.2 Middle East and Africa Anti-Ageing Drugs Market Size by Application
        10.2.1 Middle East and Africa Anti-Ageing Drugs Sales by Application (2017-2028)
        10.2.2 Middle East and Africa Anti-Ageing Drugs Revenue by Application (2017-2028)
    10.3 Middle East and Africa Anti-Ageing Drugs Market Size by Country
        10.3.1 Middle East and Africa Anti-Ageing Drugs Sales by Country (2017-2028)
        10.3.2 Middle East and Africa Anti-Ageing Drugs Revenue by Country (2017-2028)
        10.3.3 Turkey
        10.3.4 Saudi Arabia
11 Company Profiles
    11.1 Nu Skin
        11.1.1 Nu Skin Corporation Information
        11.1.2 Nu Skin Overview
        11.1.3 Nu Skin Anti-Ageing Drugs Sales, Price, Revenue and Gross Margin (2017-2022)
        11.1.4 Nu Skin Anti-Ageing Drugs Product Model Numbers, Pictures, Descriptions and Specifications
        11.1.5 Nu Skin Recent Developments
    11.2 BIOTIME
        11.2.1 BIOTIME Corporation Information
        11.2.2 BIOTIME Overview
        11.2.3 BIOTIME Anti-Ageing Drugs Sales, Price, Revenue and Gross Margin (2017-2022)
        11.2.4 BIOTIME Anti-Ageing Drugs Product Model Numbers, Pictures, Descriptions and Specifications
        11.2.5 BIOTIME Recent Developments
    11.3 Elysium Health
        11.3.1 Elysium Health Corporation Information
        11.3.2 Elysium Health Overview
        11.3.3 Elysium Health Anti-Ageing Drugs Sales, Price, Revenue and Gross Margin (2017-2022)
        11.3.4 Elysium Health Anti-Ageing Drugs Product Model Numbers, Pictures, Descriptions and Specifications
        11.3.5 Elysium Health Recent Developments
    11.4 La Roche-Posay
        11.4.1 La Roche-Posay Corporation Information
        11.4.2 La Roche-Posay Overview
        11.4.3 La Roche-Posay Anti-Ageing Drugs Sales, Price, Revenue and Gross Margin (2017-2022)
        11.4.4 La Roche-Posay Anti-Ageing Drugs Product Model Numbers, Pictures, Descriptions and Specifications
        11.4.5 La Roche-Posay Recent Developments
    11.5 DermaFix
        11.5.1 DermaFix Corporation Information
        11.5.2 DermaFix Overview
        11.5.3 DermaFix Anti-Ageing Drugs Sales, Price, Revenue and Gross Margin (2017-2022)
        11.5.4 DermaFix Anti-Ageing Drugs Product Model Numbers, Pictures, Descriptions and Specifications
        11.5.5 DermaFix Recent Developments
12 Industry Chain and Sales Channels Analysis
    12.1 Anti-Ageing Drugs Industry Chain Analysis
    12.2 Anti-Ageing Drugs Key Raw Materials
        12.2.1 Key Raw Materials
        12.2.2 Raw Materials Key Suppliers
    12.3 Anti-Ageing Drugs Production Mode & Process
    12.4 Anti-Ageing Drugs Sales and Marketing
        12.4.1 Anti-Ageing Drugs Sales Channels
        12.4.2 Anti-Ageing Drugs Distributors
    12.5 Anti-Ageing Drugs Customers
13 Market Drivers, Opportunities, Challenges and Risks Factors Analysis
    13.1 Anti-Ageing Drugs Industry Trends
    13.2 Anti-Ageing Drugs Market Drivers
    13.3 Anti-Ageing Drugs Market Challenges
    13.4 Anti-Ageing Drugs Market Restraints
14 Key Findings in The Global Anti-Ageing Drugs Study
15 Appendix
    15.1 Research Methodology
        15.1.1 Methodology/Research Approach
        15.1.2 Data Source
    15.2 Author Details
    15.3 Disclaimer
                  
              

                

                 
List of Tables
    Table 1. Global Anti-Ageing Drugs Market Size Growth Rate by Type, 2017 VS 2021 VS 2028 (US$ Million)
    Table 2. Major Manufacturers of Hormonal Therapy
    Table 3. Major Manufacturers of Antioxidants
    Table 4. Major Manufacturers of Enzymes
    Table 5. Major Manufacturers of Stem Cells
    Table 6. Major Manufacturers of Others
    Table 7. Global Anti-Ageing Drugs Market Size Growth Rate by Application, 2017 VS 2021 VS 2028 (US$ Million)
    Table 8. Global Anti-Ageing Drugs Revenue by Region: 2017 VS 2021 VS 2028 (US$ Million)
    Table 9. Global Anti-Ageing Drugs Sales by Region (2017-2022) & (K Units)
    Table 10. Global Anti-Ageing Drugs Sales Market Share by Region (2017-2022)
    Table 11. Global Anti-Ageing Drugs Sales by Region (2023-2028) & (K Units)
    Table 12. Global Anti-Ageing Drugs Sales Market Share by Region (2023-2028)
    Table 13. Global Anti-Ageing Drugs Revenue by Region (2017-2022) & (US$ Million)
    Table 14. Global Anti-Ageing Drugs Revenue Market Share by Region (2017-2022)
    Table 15. Global Anti-Ageing Drugs Revenue by Region (2023-2028) & (US$ Million)
    Table 16. Global Anti-Ageing Drugs Revenue Market Share by Region (2023-2028)
    Table 17. Global Anti-Ageing Drugs Sales by Manufacturers (2017-2022) & (K Units)
    Table 18. Global Anti-Ageing Drugs Sales Share by Manufacturers (2017-2022)
    Table 19. Global Anti-Ageing Drugs Revenue by Manufacturers (2017-2022) & (US$ Million)
    Table 20. Global Anti-Ageing Drugs Revenue Share by Manufacturers (2017-2022)
    Table 21. Anti-Ageing Drugs Price by Manufacturers (2017-2022) &(USD/Unit)
    Table 22. Global Anti-Ageing Drugs Manufacturers Market Concentration Ratio (CR5 and HHI)
    Table 23. Global Anti-Ageing Drugs by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Anti-Ageing Drugs as of 2021)
    Table 24. Anti-Ageing Drugs Manufacturing Base Distribution and Headquarters
    Table 25. Manufacturers Anti-Ageing Drugs Product Offered
    Table 26. Date of Manufacturers Enter into Anti-Ageing Drugs Market
    Table 27. Mergers & Acquisitions, Expansion Plans
    Table 28. Global Anti-Ageing Drugs Sales by Type (2017-2022) & (K Units)
    Table 29. Global Anti-Ageing Drugs Sales by Type (2023-2028) & (K Units)
    Table 30. Global Anti-Ageing Drugs Sales Share by Type (2017-2022)
    Table 31. Global Anti-Ageing Drugs Sales Share by Type (2023-2028)
    Table 32. Global Anti-Ageing Drugs Revenue by Type (2017-2022) & (US$ Million)
    Table 33. Global Anti-Ageing Drugs Revenue by Type (2023-2028) & (US$ Million)
    Table 34. Global Anti-Ageing Drugs Revenue Share by Type (2017-2022)
    Table 35. Global Anti-Ageing Drugs Revenue Share by Type (2023-2028)
    Table 36. Anti-Ageing Drugs Price by Type (2017-2022) & (USD/Unit)
    Table 37. Global Anti-Ageing Drugs Price Forecast by Type (2023-2028) & (USD/Unit)
    Table 38. Global Anti-Ageing Drugs Sales by Application (2017-2022) & (K Units)
    Table 39. Global Anti-Ageing Drugs Sales by Application (2023-2028) & (K Units)
    Table 40. Global Anti-Ageing Drugs Sales Share by Application (2017-2022)
    Table 41. Global Anti-Ageing Drugs Sales Share by Application (2023-2028)
    Table 42. Global Anti-Ageing Drugs Revenue by Application (2017-2022) & (US$ Million)
    Table 43. Global Anti-Ageing Drugs Revenue by Application (2023-2028) & (US$ Million)
    Table 44. Global Anti-Ageing Drugs Revenue Share by Application (2017-2022)
    Table 45. Global Anti-Ageing Drugs Revenue Share by Application (2023-2028)
    Table 46. Anti-Ageing Drugs Price by Application (2017-2022) & (USD/Unit)
    Table 47. Global Anti-Ageing Drugs Price Forecast by Application (2023-2028) & (USD/Unit)
    Table 48. North America Anti-Ageing Drugs Sales by Type (2017-2022) & (K Units)
    Table 49. North America Anti-Ageing Drugs Sales by Type (2023-2028) & (K Units)
    Table 50. North America Anti-Ageing Drugs Revenue by Type (2017-2022) & (US$ Million)
    Table 51. North America Anti-Ageing Drugs Revenue by Type (2023-2028) & (US$ Million)
    Table 52. North America Anti-Ageing Drugs Sales by Application (2017-2022) & (K Units)
    Table 53. North America Anti-Ageing Drugs Sales by Application (2023-2028) & (K Units)
    Table 54. North America Anti-Ageing Drugs Revenue by Application (2017-2022) & (US$ Million)
    Table 55. North America Anti-Ageing Drugs Revenue by Application (2023-2028) & (US$ Million)
    Table 56. North America Anti-Ageing Drugs Sales by Country (2017-2022) & (K Units)
    Table 57. North America Anti-Ageing Drugs Sales by Country (2023-2028) & (K Units)
    Table 58. North America Anti-Ageing Drugs Revenue by Country (2017-2022) & (US$ Million)
    Table 59. North America Anti-Ageing Drugs Revenue by Country (2023-2028) & (US$ Million)
    Table 60. Europe Anti-Ageing Drugs Sales by Type (2017-2022) & (K Units)
    Table 61. Europe Anti-Ageing Drugs Sales by Type (2023-2028) & (K Units)
    Table 62. Europe Anti-Ageing Drugs Revenue by Type (2017-2022) & (US$ Million)
    Table 63. Europe Anti-Ageing Drugs Revenue by Type (2023-2028) & (US$ Million)
    Table 64. Europe Anti-Ageing Drugs Sales by Application (2017-2022) & (K Units)
    Table 65. Europe Anti-Ageing Drugs Sales by Application (2023-2028) & (K Units)
    Table 66. Europe Anti-Ageing Drugs Revenue by Application (2017-2022) & (US$ Million)
    Table 67. Europe Anti-Ageing Drugs Revenue by Application (2023-2028) & (US$ Million)
    Table 68. Europe Anti-Ageing Drugs Sales by Country (2017-2022) & (K Units)
    Table 69. Europe Anti-Ageing Drugs Sales by Country (2023-2028) & (K Units)
    Table 70. Europe Anti-Ageing Drugs Revenue by Country (2017-2022) & (US$ Million)
    Table 71. Europe Anti-Ageing Drugs Revenue by Country (2023-2028) & (US$ Million)
    Table 72. Asia Pacific Anti-Ageing Drugs Sales by Type (2017-2022) & (K Units)
    Table 73. Asia Pacific Anti-Ageing Drugs Sales by Type (2023-2028) & (K Units)
    Table 74. Asia Pacific Anti-Ageing Drugs Revenue by Type (2017-2022) & (US$ Million)
    Table 75. Asia Pacific Anti-Ageing Drugs Revenue by Type (2023-2028) & (US$ Million)
    Table 76. Asia Pacific Anti-Ageing Drugs Sales by Application (2017-2022) & (K Units)
    Table 77. Asia Pacific Anti-Ageing Drugs Sales by Application (2023-2028) & (K Units)
    Table 78. Asia Pacific Anti-Ageing Drugs Revenue by Application (2017-2022) & (US$ Million)
    Table 79. Asia Pacific Anti-Ageing Drugs Revenue by Application (2023-2028) & (US$ Million)
    Table 80. Asia Pacific Anti-Ageing Drugs Sales by Region (2017-2022) & (K Units)
    Table 81. Asia Pacific Anti-Ageing Drugs Sales by Region (2023-2028) & (K Units)
    Table 82. Asia Pacific Anti-Ageing Drugs Revenue by Region (2017-2022) & (US$ Million)
    Table 83. Asia Pacific Anti-Ageing Drugs Revenue by Region (2023-2028) & (US$ Million)
    Table 84. Latin America Anti-Ageing Drugs Sales by Type (2017-2022) & (K Units)
    Table 85. Latin America Anti-Ageing Drugs Sales by Type (2023-2028) & (K Units)
    Table 86. Latin America Anti-Ageing Drugs Revenue by Type (2017-2022) & (US$ Million)
    Table 87. Latin America Anti-Ageing Drugs Revenue by Type (2023-2028) & (US$ Million)
    Table 88. Latin America Anti-Ageing Drugs Sales by Application (2017-2022) & (K Units)
    Table 89. Latin America Anti-Ageing Drugs Sales by Application (2023-2028) & (K Units)
    Table 90. Latin America Anti-Ageing Drugs Revenue by Application (2017-2022) & (US$ Million)
    Table 91. Latin America Anti-Ageing Drugs Revenue by Application (2023-2028) & (US$ Million)
    Table 92. Latin America Anti-Ageing Drugs Sales by Country (2017-2022) & (K Units)
    Table 93. Latin America Anti-Ageing Drugs Sales by Country (2023-2028) & (K Units)
    Table 94. Latin America Anti-Ageing Drugs Revenue by Country (2017-2022) & (US$ Million)
    Table 95. Latin America Anti-Ageing Drugs Revenue by Country (2023-2028) & (US$ Million)
    Table 96. Middle East and Africa Anti-Ageing Drugs Sales by Type (2017-2022) & (K Units)
    Table 97. Middle East and Africa Anti-Ageing Drugs Sales by Type (2023-2028) & (K Units)
    Table 98. Middle East and Africa Anti-Ageing Drugs Revenue by Type (2017-2022) & (US$ Million)
    Table 99. Middle East and Africa Anti-Ageing Drugs Revenue by Type (2023-2028) & (US$ Million)
    Table 100. Middle East and Africa Anti-Ageing Drugs Sales by Application (2017-2022) & (K Units)
    Table 101. Middle East and Africa Anti-Ageing Drugs Sales by Application (2023-2028) & (K Units)
    Table 102. Middle East and Africa Anti-Ageing Drugs Revenue by Application (2017-2022) & (US$ Million)
    Table 103. Middle East and Africa Anti-Ageing Drugs Revenue by Application (2023-2028) & (US$ Million)
    Table 104. Middle East and Africa Anti-Ageing Drugs Sales by Country (2017-2022) & (K Units)
    Table 105. Middle East and Africa Anti-Ageing Drugs Sales by Country (2023-2028) & (K Units)
    Table 106. Middle East and Africa Anti-Ageing Drugs Revenue by Country (2017-2022) & (US$ Million)
    Table 107. Middle East and Africa Anti-Ageing Drugs Revenue by Country (2023-2028) & (US$ Million)
    Table 108. Nu Skin Corporation Information
    Table 109. Nu Skin Description and Major Businesses
    Table 110. Nu Skin Anti-Ageing Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
    Table 111. Nu Skin Anti-Ageing Drugs Product Model Numbers, Pictures, Descriptions and Specifications
    Table 112. Nu Skin Recent Developments
    Table 113. BIOTIME Corporation Information
    Table 114. BIOTIME Description and Major Businesses
    Table 115. BIOTIME Anti-Ageing Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
    Table 116. BIOTIME Anti-Ageing Drugs Product Model Numbers, Pictures, Descriptions and Specifications
    Table 117. BIOTIME Recent Developments
    Table 118. Elysium Health Corporation Information
    Table 119. Elysium Health Description and Major Businesses
    Table 120. Elysium Health Anti-Ageing Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
    Table 121. Elysium Health Anti-Ageing Drugs Product Model Numbers, Pictures, Descriptions and Specifications
    Table 122. Elysium Health Recent Developments
    Table 123. La Roche-Posay Corporation Information
    Table 124. La Roche-Posay Description and Major Businesses
    Table 125. La Roche-Posay Anti-Ageing Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
    Table 126. La Roche-Posay Anti-Ageing Drugs Product Model Numbers, Pictures, Descriptions and Specifications
    Table 127. La Roche-Posay Recent Developments
    Table 128. DermaFix Corporation Information
    Table 129. DermaFix Description and Major Businesses
    Table 130. DermaFix Anti-Ageing Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
    Table 131. DermaFix Anti-Ageing Drugs Product Model Numbers, Pictures, Descriptions and Specifications
    Table 132. DermaFix Recent Developments
    Table 133. Key Raw Materials Lists
    Table 134. Raw Materials Key Suppliers Lists
    Table 135. Anti-Ageing Drugs Distributors List
    Table 136. Anti-Ageing Drugs Customers List
    Table 137. Anti-Ageing Drugs Market Trends
    Table 138. Anti-Ageing Drugs Market Drivers
    Table 139. Anti-Ageing Drugs Market Challenges
    Table 140. Anti-Ageing Drugs Market Restraints
    Table 141. Research Programs/Design for This Report
    Table 142. Key Data Information from Secondary Sources
    Table 143. Key Data Information from Primary Sources
List of Figures
    Figure 1. Anti-Ageing Drugs Product Picture
    Figure 3. Global Anti-Ageing Drugs Market Share by Type in 2021 & 2028
    Figure 3. Hormonal Therapy Product Picture
    Figure 4. Antioxidants Product Picture
    Figure 5. Enzymes Product Picture
    Figure 6. Stem Cells Product Picture
    Figure 7. Others Product Picture
    Figure 8. Global Anti-Ageing Drugs Market Share by Application in 2021 & 2028
    Figure 9. Skin
    Figure 10. Hair
    Figure 11. Others
    Figure 12. Anti-Ageing Drugs Report Years Considered
    Figure 13. Global Anti-Ageing Drugs Sales 2017-2028 (K Units)
    Figure 14. Global Anti-Ageing Drugs Revenue, (US$ Million), 2017 VS 2021 VS 2028
    Figure 15. Global Anti-Ageing Drugs Revenue 2017-2028 (US$ Million)
    Figure 16. Global Anti-Ageing Drugs Revenue Market Share by Region in Percentage: 2021 Versus 2028
    Figure 17. Global Anti-Ageing Drugs Sales Market Share by Region (2017-2022)
    Figure 18. Global Anti-Ageing Drugs Sales Market Share by Region (2023-2028)
    Figure 19. North America Anti-Ageing Drugs Sales YoY (2017-2028) & (K Units)
    Figure 20. North America Anti-Ageing Drugs Revenue YoY (2017-2028) & (US$ Million)
    Figure 21. Europe Anti-Ageing Drugs Sales YoY (2017-2028) & (K Units)
    Figure 22. Europe Anti-Ageing Drugs Revenue YoY (2017-2028) & (US$ Million)
    Figure 23. Asia-Pacific Anti-Ageing Drugs Sales YoY (2017-2028) & (K Units)
    Figure 24. Asia-Pacific Anti-Ageing Drugs Revenue YoY (2017-2028) & (US$ Million)
    Figure 25. Latin America Anti-Ageing Drugs Sales YoY (2017-2028) & (K Units)
    Figure 26. Latin America Anti-Ageing Drugs Revenue YoY (2017-2028) & (US$ Million)
    Figure 27. Middle East & Africa Anti-Ageing Drugs Sales YoY (2017-2028) & (K Units)
    Figure 28. Middle East & Africa Anti-Ageing Drugs Revenue YoY (2017-2028) & (US$ Million)
    Figure 29. The Anti-Ageing Drugs Market Share of Top 10 and Top 5 Largest Manufacturers Around the World in 2021
    Figure 30. The Top 5 and 10 Largest Manufacturers of Anti-Ageing Drugs in the World: Market Share by Anti-Ageing Drugs Revenue in 2021
    Figure 31. Global Anti-Ageing Drugs Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2017 VS 2021
    Figure 32. Global Anti-Ageing Drugs Sales Market Share by Type (2017-2028)
    Figure 33. Global Anti-Ageing Drugs Revenue Market Share by Type (2017-2028)
    Figure 34. Global Anti-Ageing Drugs Sales Market Share by Application (2017-2028)
    Figure 35. Global Anti-Ageing Drugs Revenue Market Share by Application (2017-2028)
    Figure 36. North America Anti-Ageing Drugs Sales Market Share by Type (2017-2028)
    Figure 37. North America Anti-Ageing Drugs Revenue Market Share by Type (2017-2028)
    Figure 38. North America Anti-Ageing Drugs Sales Market Share by Application (2017-2028)
    Figure 39. North America Anti-Ageing Drugs Revenue Market Share by Application (2017-2028)
    Figure 40. North America Anti-Ageing Drugs Sales Share by Country (2017-2028)
    Figure 41. North America Anti-Ageing Drugs Revenue Share by Country (2017-2028)
    Figure 42. U.S. Anti-Ageing Drugs Revenue (2017-2028) & (US$ Million)
    Figure 43. Canada Anti-Ageing Drugs Revenue (2017-2028) & (US$ Million)
    Figure 44. Europe Anti-Ageing Drugs Sales Market Share by Type (2017-2028)
    Figure 45. Europe Anti-Ageing Drugs Revenue Market Share by Type (2017-2028)
    Figure 46. Europe Anti-Ageing Drugs Sales Market Share by Application (2017-2028)
    Figure 47. Europe Anti-Ageing Drugs Revenue Market Share by Application (2017-2028)
    Figure 48. Europe Anti-Ageing Drugs Sales Share by Country (2017-2028)
    Figure 49. Europe Anti-Ageing Drugs Revenue Share by Country (2017-2028)
    Figure 50. Germany Anti-Ageing Drugs Revenue (2017-2028) & (US$ Million)
    Figure 51. France Anti-Ageing Drugs Revenue (2017-2028) & (US$ Million)
    Figure 52. U.K. Anti-Ageing Drugs Revenue (2017-2028) & (US$ Million)
    Figure 53. Italy Anti-Ageing Drugs Revenue (2017-2028) & (US$ Million)
    Figure 54. Russia Anti-Ageing Drugs Revenue (2017-2028) & (US$ Million)
    Figure 55. Asia Pacific Anti-Ageing Drugs Sales Market Share by Type (2017-2028)
    Figure 56. Asia Pacific Anti-Ageing Drugs Revenue Market Share by Type (2017-2028)
    Figure 57. Asia Pacific Anti-Ageing Drugs Sales Market Share by Application (2017-2028)
    Figure 58. Asia Pacific Anti-Ageing Drugs Revenue Market Share by Application (2017-2028)
    Figure 59. Asia Pacific Anti-Ageing Drugs Sales Share by Region (2017-2028)
    Figure 60. Asia Pacific Anti-Ageing Drugs Revenue Share by Region (2017-2028)
    Figure 61. China Anti-Ageing Drugs Revenue (2017-2028) & (US$ Million)
    Figure 62. Japan Anti-Ageing Drugs Revenue (2017-2028) & (US$ Million)
    Figure 63. South Korea Anti-Ageing Drugs Revenue (2017-2028) & (US$ Million)
    Figure 64. India Anti-Ageing Drugs Revenue (2017-2028) & (US$ Million)
    Figure 65. Australia Anti-Ageing Drugs Revenue (2017-2028) & (US$ Million)
    Figure 66. Taiwan Anti-Ageing Drugs Revenue (2017-2028) & (US$ Million)
    Figure 67. Indonesia Anti-Ageing Drugs Revenue (2017-2028) & (US$ Million)
    Figure 68. Thailand Anti-Ageing Drugs Revenue (2017-2028) & (US$ Million)
    Figure 69. Malaysia Anti-Ageing Drugs Revenue (2017-2028) & (US$ Million)
    Figure 70. Philippines Anti-Ageing Drugs Revenue (2017-2028) & (US$ Million)
    Figure 71. Latin America Anti-Ageing Drugs Sales Market Share by Type (2017-2028)
    Figure 72. Latin America Anti-Ageing Drugs Revenue Market Share by Type (2017-2028)
    Figure 73. Latin America Anti-Ageing Drugs Sales Market Share by Application (2017-2028)
    Figure 74. Latin America Anti-Ageing Drugs Revenue Market Share by Application (2017-2028)
    Figure 75. Latin America Anti-Ageing Drugs Sales Share by Country (2017-2028)
    Figure 76. Latin America Anti-Ageing Drugs Revenue Share by Country (2017-2028)
    Figure 77. Mexico Anti-Ageing Drugs Revenue (2017-2028) & (US$ Million)
    Figure 78. Brazil Anti-Ageing Drugs Revenue (2017-2028) & (US$ Million)
    Figure 79. Argentina Anti-Ageing Drugs Revenue (2017-2028) & (US$ Million)
    Figure 80. Middle East and Africa Anti-Ageing Drugs Sales Market Share by Type (2017-2028)
    Figure 81. Middle East and Africa Anti-Ageing Drugs Revenue Market Share by Type (2017-2028)
    Figure 82. Middle East and Africa Anti-Ageing Drugs Sales Market Share by Application (2017-2028)
    Figure 83. Middle East and Africa Anti-Ageing Drugs Revenue Market Share by Application (2017-2028)
    Figure 84. Middle East and Africa Anti-Ageing Drugs Sales Share by Country (2017-2028)
    Figure 85. Middle East and Africa Anti-Ageing Drugs Revenue Share by Country (2017-2028)
    Figure 86. Turkey Anti-Ageing Drugs Revenue (2017-2028) & (US$ Million)
    Figure 87. Saudi Arabia Anti-Ageing Drugs Revenue (2017-2028) & (US$ Million)
    Figure 88. U.A.E Anti-Ageing Drugs Revenue (2017-2028) & (US$ Million)
    Figure 89. Anti-Ageing Drugs Value Chain
    Figure 90. Anti-Ageing Drugs Production Process
    Figure 91. Channels of Distribution
    Figure 92. Distributors Profiles
    Figure 93. Bottom-up and Top-down Approaches for This Report
    Figure 94. Data Triangulation
    Figure 95. Key Executives Interviewed